USE OF AN ANTI-CONNECTIVE TISSUE GROWTH FACTOR AGENT FOR THE MANUFACTURE OF A MEDICAMENT FOR REDUCING VASCULAR DYSFUNCTION OR IMPROVING VASCULAR FUNCTION

摘要

The present invention relates to methods for treating impaired cardiac function. Methods for treating various physiological and pathological features associated with cardiac dysfunction by administering an agent that inhibits the expression or activity of connective tissue growth factor (CTGF) are provided.